Hinze et al. reported that GSK3α inhibition was sufficient for ASNase sensitization in APC or β-catenin mutant CRC, although ASNase had little effect on APC or β-catenin mutant CRC [70]. This evidence concerns the gene APC and colorectal carcinoma.